LANDOS BIOPHARMA
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases.The company's therapeutics are novel, locally-acting small molecules targeting inflammatory bowel disease (IBD), crohn's disease (CD) and ulcerative colitis (UC), enabling healthcare providers to cure their patients.
LANDOS BIOPHARMA
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical Therapeutics
Founded:
2017-06-01
Address:
Blacksburg, Virginia, United States
Country:
United States
Website Url:
http://www.landosbiopharma.com
Total Employee:
11+
Status:
Active
Contact:
(540) 218-2232
Email Addresses:
[email protected]
Total Funding:
70 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Domain Not Resolving
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Navitor Pharmaceuticals
Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Chris Garabedian
Chris Garabedian investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series B - Landos Biopharma
PBM Capital Group
PBM Capital Group investment in Series B - Landos Biopharma
RTW Investments LLC
RTW Investments LLC investment in Series B - Landos Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Landos Biopharma
Helicase Venture
Helicase Venture investment in Series B - Landos Biopharma
Perceptive Advisors
Perceptive Advisors investment in Series A - Landos Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-21 | Landos Names Gregory Oakes President and Chief Executive Officer |
Official Site Inspections
http://www.landosbiopharma.com Semrush global rank: 4.94 M Semrush visits lastest month: 1.74 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "Landos Biopharma"
Landos Biopharma - AbbVie
We're building on our deep expertise and legacy in immunology research to explore new disease areas, create a more patient-centric discovery and development process and offer solutions …See details»
AbbVie Completes Acquisition of Landos Biopharma
May 23, 2024 · With the completion of the acquisition, Landos is now part of AbbVie. Landos' lead investigational asset is NX-13, a first-in-class, oral NLRX1 agonist (a member of the NOD-like …See details»
AbbVie to Acquire Landos Biopharma, Further Strengthening its …
Mar 25, 2024 · Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its …See details»
AbbVie to Acquire Landos Biopharma, Further Strengthening its …
Mar 25, 2024 · AbbVie Inc. (NYSE: ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ: LABP) ("Landos") today announced a definitive agreement under which AbbVie will acquire …See details»
Landos Biopharma - Craft
May 23, 2024 · Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune disease.See details»
Landos Biopharma - Crunchbase Company Profile & Funding
Landos Biopharma is a developer of an oral first-in-class therapeutics designed to target autoimmune diseases. View contacts for Landos Biopharma to access new leads and connect …See details»
Landos Biopharma, Inc. Information - RocketReach
Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class therapeutics for patients with autoimmune disease. The Company’s mission is to …See details»
Landos Biopharma Company Profile 2024: Valuation, Investors
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases. It has several …See details»
Landos Biopharma - VentureRadar
"Landos Biopharma is a clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with autoimmune disease. Landos …See details»
Landos Biopharma - Overview, News & Competitors | ZoomInfo.com
Landos Biopharma contact info: Phone number: (540) 218-2232 Website: www.landosbiopharma.com What does Landos Biopharma do? Landos Biopharma, Inc., a …See details»
AbbVie to Acquire Landos Biopharma, Further Strengthening its …
Mar 25, 2024 · Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its …See details»
Landos Biopharma CEO and Key Executive Team | Craft.co
Landos Biopharma's key executives include Tim M. Mayleben and 4 others. Need Data? Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via …See details»
Landos Biopharma, Inc. | Insights
Mar 29, 2024 · Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
Landos Biopharma Reports Third Quarter 2022 Results and …
NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company developing novel, oral medicines for patients with …See details»
Landos Biopharma completes $60 million Series | EurekAlert!
Aug 14, 2019 · Landos Biopharma, Inc. is a clinical-s tage biopharmaceutical company focused on the discovery and development of first-in-class oral therapeutics for patients with …See details»
Landos Biopharma Announces First Subject Dosed in a Phase 1
Oct 28, 2021 · “We are pleased to announce the initiation of the first clinical trial investigating LABP-104, marking Landos’ sixth novel clinical program addressing the unmet clinical needs …See details»
Landos Biopharma and LianBio Announce Exclusive - GlobeNewswire
May 17, 2021 · Landos Biopharma is a clinical-stage biopharmaceutical company utilizing its LANCE A.I. platform to discover and develop novel oral therapeutics for patients with …See details»
Landos Biopharma 与联拓生物宣布独家合作和许可协议 - 丁香园
May 20, 2021 · Landos Biopharma 是一家处于临床阶段的生物制药公司，专注于利用其 LANCE 人工智能平台为自身免疫疾病患者研发新型口服治疗药物。 公司基于 LANCE 人工智能平台已 …See details»
AbbVie to Acquire Landos Biopharma, Further Strengthening
Mar 25, 2024 · Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its …See details»
AbbVie to Acquire Landos Biopharma, Further ... - Markets Insider
Mar 25, 2024 · Landos Biopharma is a clinical stage biopharmaceutical company focused on the development of first-in-class, oral therapeutics for patients with autoimmune diseases. Its …See details»